KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Sep 2025 value amounting to -$4.9 million.

  • Rigel Pharmaceuticals' Net Cash Flow fell 131.16% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 149.39%. This contributed to the annual value of $24.0 million for FY2024, which is 187.74% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Net Cash Flow stood at -$4.9 million for Q3 2025, which was down 163.46% from $7.7 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' Net Cash Flow's 5-year high stood at $64.8 million during Q2 2021, with a 5-year trough of -$54.4 million in Q3 2021.
  • In the last 3 years, Rigel Pharmaceuticals' Net Cash Flow had a median value of $5.1 million in 2024 and averaged $2.2 million.
  • Within the past 5 years, the most significant YoY rise in Rigel Pharmaceuticals' Net Cash Flow was 839.79% (2021), while the steepest drop was 55,630.61% (2021).
  • Rigel Pharmaceuticals' Net Cash Flow (Quarterly) stood at -$11.5 million in 2021, then spiked by 53.04% to -$5.4 million in 2022, then crashed by 133.55% to -$12.6 million in 2023, then spiked by 140.02% to $5.1 million in 2024, then slumped by 131.16% to -$4.9 million in 2025.
  • Its Net Cash Flow was -$4.9 million in Q3 2025, compared to $7.7 million in Q2 2025 and -$11.0 million in Q1 2025.